For many, the threat of the COVID-19 pandemic seems over. However, for patients whose immune systems are compromised by cancer or by cancer therapies, fear of COVID-19 infection and severe disease remains very real. Currently, CDC guidance recommends that immunocompromised patients receive COVID-19 booster shots “as needed.” While this flexibility is useful for patients with complex medical conditions, more specific guidance is lacking as to when additional COVID-19 boosting would be most effective. New research led by scientists at Yale University and the University of North Carolina at Charlotte provides this critically needed information. The rate at which additional COVID-19 boosters…

Cancer patients saw a significant fall in Covid-related hospitalisations and mortality following the rollout of vaccines in the first panoramic study of its kind. The research published in Scientific Reports looked at the impact of the global pandemic on case-outcome rates for cancer patients across a 21-month period from November 2020 to August 2022. The team of researchers led by the University of Birmingham found that hospitalisations in the period fell from nearly one in three patients (30.58%) to one in 13 patients (7.45%); and, case-mortality rates fell from more than one in five patients (20.53%) to less than one in 30…